By leveraging our long-lasting European expertise in 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀, 𝗼𝗿𝗽𝗵𝗮𝗻 𝗱𝗿𝘂𝗴𝘀 𝗮𝗻𝗱 𝗻𝗶𝗰𝗵𝗲 𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀, BlueDil International can help you navigate the complexities of rare disease pharma, to unleash the full potential of your business in Europe.
Our strategic and operational services will 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝘆𝗼𝘂𝗿 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀’ 𝗹𝗶𝗳𝗲𝗰𝘆𝗰𝗹𝗲, 𝗳𝗿𝗼𝗺 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝘁𝗼 𝗽𝗿𝗲-𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 𝗮𝗻𝗱 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻.

We will develop and enhance your relationships at country and regional level, engaging with all relevant European stakeholders, building your own network of Scientific Societies, KOLs and HCPs, PAGs, Regulatory bodies, Payers and Policymakers.

Our customized approach, aimed to reach excellence and success, is key to thriving in this dynamic environment.

𝗪𝗵𝗮𝘁 𝗰𝗮𝗻 𝘄𝗲 𝗼𝗳𝗳𝗲𝗿? 
🔹Access to highly experienced local consultants through a single-entry point
🔹A cost-effectiveness and low risk business approach
🔹Time and coordination effectiveness - plug and play missions, started within one month
🔹A flexible working method, which allows to quickly deliver
🔹No internal employees to hire and manage

𝗕𝗹𝘂𝗲𝗗𝗶𝗹 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗶𝗻… 𝗻𝘂𝗺𝗯𝗲𝗿𝘀: 
➡️More than 50 missions in severe and rare diseases
➡️More than 25 orphan drugs companies followed and for which our founding members have acted as General Managers
➡️More than 160 years of cumulated experience of the founding members in severe and rare diseases 

With offices in France, Germany, Italy, Spain and the United Kingdom, we provide extensive coverage across Europe. Our successfully expansion into Japan and our representative presence in the US (Cambridge, MA and New York) allow us to better serve our clients worldwide.

BlueDil International

Org chart

Teams

Offices